Cancer Research SABCS  Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pervin, S.
Right arrow Articles by Chaudhuri, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pervin, S.
Right arrow Articles by Chaudhuri, G.
[Cancer Research 61, 4701-4706, June 15, 2001]
© 2001 American Association for Cancer Research


Carcinogenesis

Potentiation of Nitric Oxide-induced Apoptosis of MDA-MB-468 Cells by Farnesyltransferase Inhibitor

Implications in Breast Cancer1

Shehla Pervin, Rajan Singh, Chia-Ling Gau, Hironori Edamatsu, Fuyuhiko Tamanoi and Gautam Chaudhuri2

Departments of Obstetrics & Gynecology [S. P., R. S., G. C.], Molecular and Medical Pharmacology [S. P., R. S., G. C.], and Microbiology and Molecular Genetics [C-L. G., H. E., F. T.], and Jonsson Comprehensive Cancer Center [F. T., G. C.], University of California School of Medicine, Los Angeles, California 90095-1740

High amounts of nitric oxide (NO) produced by activated macrophages or NO donors are required to induce cytotoxicity and apoptosis in pathogens and tumor cells. High concentrations of NO may lead to nonspecific toxicity thereby limiting the use of NO donors in the treatment of cancer. In this study, we tested the possibility of potentiating the apoptotic action of NO in a human breast cancer cell line, MDA-MB-468, by combining it with a farnesyltransferase inhibitor (FTI), which has been shown to induce apoptosis in some other cancer cell lines with minimal toxicity to normal cells. DETA-NONOate, a long acting NO donor which has a half-life of 20 h at 37°C, was used in this study. DETA-NONOate (1 mM), which releases NO in the range produced by activated macrophages, induced apoptosis after 36 h in MDA-MB-468 cells via cytochrome c release and caspase-9 and -3 activation. FTI (25 µM) potentiated the action of lower concentrations of DETA-NONOate (25–100 µM) by inducing apoptosis in these cells within 24 h by increasing cytochrome c release and caspase-9 and -3 activation. This effect was observed preferentially in the cancer cell lines studied with no apoptosis induction in normal breast epithelial cells. This novel combination of FTI and NO may emerge as a promising approach for the treatment of breast cancer.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Pervin, R. Singh, E. Hernandez, G. Wu, and G. Chaudhuri
Nitric Oxide in Physiologic Concentrations Targets the Translational Machinery to Increase the Proliferation of Human Breast Cancer Cells: Involvement of Mammalian Target of Rapamycin/eIF4E Pathway
Cancer Res., January 1, 2007; 67(1): 289 - 299.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. M. Howells, E. A. Hudson, and M. M. Manson
Inhibition of Phosphatidylinositol 3-Kinase/Protein Kinase B Signaling Is Not Sufficient to Account for Indole-3-Carbinol-Induced Apoptosis in Some Breast and Prostate Tumor Cells
Clin. Cancer Res., December 1, 2005; 11(23): 8521 - 8527.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. J. Van Lenten, A. C. Wagner, M. Navab, G.M. Anantharamaiah, E. K.-W. Hui, D. P. Nayak, and A. M. Fogelman
D-4F, an Apolipoprotein A-I Mimetic Peptide, Inhibits the Inflammatory Response Induced by Influenza A Infection of Human Type II Pneumocytes
Circulation, November 16, 2004; 110(20): 3252 - 3258.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Pervin, R. Singh, W. A. Freije, and G. Chaudhuri
MKP-1-Induced Dephosphorylation of Extracellular Signal-Regulated Kinase Is Essential for Triggering Nitric Oxide-Induced Apoptosis in Human Breast Cancer Cell Lines: Implications in Breast Cancer
Cancer Res., December 15, 2003; 63(24): 8853 - 8860.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Pervin, R. Singh, and G. Chaudhuri
Nitric-Oxide-induced Bax Integration into the Mitochondrial Membrane Commits MDA-MB-468 Cells to Apoptosis: Essential Role of Akt
Cancer Res., September 1, 2003; 63(17): 5470 - 5479.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Selleri, J. P. Maciejewski, N. Montuori, P. Ricci, V. Visconte, B. Serio, L. Luciano, and B. Rotoli
Involvement of nitric oxide in farnesyltransferase inhibitor-mediated apoptosis in chronic myeloid leukemia cells
Blood, August 15, 2003; 102(4): 1490 - 1498.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Singh, S. Pervin, and G. Chaudhuri
Caspase-8-mediated BID Cleavage and Release of Mitochondrial Cytochrome c during Nomega -Hydroxy-L-arginine-induced Apoptosis in MDA-MB-468 Cells. ANTAGONISTIC EFFECTS OF L-ORNITHINE
J. Biol. Chem., September 27, 2002; 277(40): 37630 - 37636.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.